Oxidative Stress Assay Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 9.00 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Oxidative Stress Assay Market Analysis
The Oxidative Stress Assay Market is projected to register a CAGR of 9% during the forecast period (2022-2027).
Amidst COVID-19, the oxidative stress assay market is expected to grow due to the increasing investment in research and development activities across the globe. According to the article titled "Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants" published in May 2021, oxidative stress and inflammation are intertwined processes that play a vital role in disease progression and response to therapy via interference with multiple signaling pathways. The redox status of a host cell is an important factor in viral entry due to the unique conditions required for the conformational changes that ensure the binding and entry of a virus into the host cell. Such studies demonstrate how oxidative stress assays can be useful in finding COVID-19 progression and may propel the growth of the market over the coming years.
The rapid growth in the biopharmaceutical and biotechnology industries and the increase in chronic disorders are among the major factors expected to drive the growth of the oxidative stress assay market. According to the Center for Disease Control and Prevention (CDC) May 2022 update, six in ten adults in the United States have a chronic disease, and four in ten adults have two or more. Such a high prevalence of chronic diseases increased the demand for oxidative stress assays owing to the increased efficacy and precision of the results as chronic disorders result in an imbalance in oxidant and antioxidant levels.
Additionally, the increasing research studies to widen the application of the oxidative stress assay in different diseases is also propelling the growth of the market. For instance, the article titled "Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy" published in September 2021 reported that as concentrations increased, Reactive Oxygen Species (ROS) paradoxically influenced cancer development, either triggering tumorigenesis or supporting the proliferation of cancer cells at moderate levels of ROS or causing cancer cell death at high levels of ROS. Thus, ROS can be considered an attractive target for the therapy of cancer. It also reported that the use of ROS-based repurposed drugs may be one of the promising ways to overcome current cancer treatment challenges. Such research studies could lead to the development of new products and increasing applications in cancer diagnostics and therapeutics and hence may drive the growth of the market in the near future.
Therefore, due to the aforesaid factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and the lack of trained personnel to handle the equipment may hamper the market's growth.
Oxidative Stress Assay Market Trends
This section covers the major market trends shaping the Oxidative Stress Assay Market according to our research experts:
The Pharmaceutical and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Oxidative Stress Assay Market.
By end user, the pharmaceutical and biotechnology industries segment is anticipated to garner the largest share of the market. The sudden outbreak of COVID-19 has increased the demand for oxidative stress assays as these products play a major role in the research and development of the pharmaceutical and biotechnology industries. The surge in research and development investments in the pharmaceutical and biotechnology industries is expected to boost the segment's growth since oxidative stress assays are widely used in the product development process. For instance, the data published by the Organisation for Economic Development and Co-operation (OECD) in 2021 reported that research and development investment intensity in the pharmaceutical and biotechnology sectors in the United States surpassed the 3% milestone, while in China it was 2.1% to 2.2% from the past year. The report also stated that Europe experienced a more modest increase of 2.1 percent in research and development expenditure.
Additionally, the approval of products by the regulatory authorities and the launch of newer products are also contributing to the growth of the segment. For instance, in June 2022, AMSBIO expanded its range of antibodies, biomarkers, and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants), and antioxidants for researchers investigating the mechanism of oxidative stress.
Considering these factors, the pharmaceutical and biotechnology industry segment is expected to hold the major market share as they employ a significant number of oxidative stress assay products for the R&D of newer disease diagnoses.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
The ever-increasing demand from biopharma and biotechnology companies in this region is expected to drive the growth of the oxidative stress assay market in North America. Moreover, the increase in the adoption of technologically advanced equipment and the presence of more experienced professionals is expected to propel the market growth in this region. Also, the increasing launches of new products by biopharma companies is a contributing factor to the growth of the market as oxidative stress assays play a crucial role in biopharmaceutical production.
Additionally, an upsurge in investment in research and development in the biotechnology sector in the United States is a major contributing factor to the growth of the oxidative stress assay market in this region. For instance, California-based Amgen Inc. invested heavily in its research and development activities and its expenditure for research and development was USD 4.8 billion, USD 4.2 billion, and USD 4.1 billion for 2021, 2020, and 2019, respectively.
Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in July 2021, ImmuchromGmbH signed a partnership agreement with Ilex Life Sciences for North American distribution of gastrointestinal biomarker assays. Immuchrom is a German developer and manufacturer of HPLC applications, photometric assays, and immunoassays, specializing in areas of gastrointestinal disease, the cardiovascular system, oxidative stress, and calcium and bone metabolism. Such initiatives are also boosting the growth of the market.
Thus, considering all these factors, North America is expected to hold a major share in the oxidative stress market.
Oxidative Stress Assay Industry Overview
The oxidative stress assay market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Abcam Plc, AMSBIO, Biovision Inc, Cell Biolabs, Inc, Enzo Life Sciences, Inc, Merck KGaA, Immunochemistry Technologies, Promega Corporation, Qiagen, Thermo Fisher Scientific, and others.
Oxidative Stress Assay Market Leaders
-
Abcam plc
-
AMSBIO
-
Merck KGaA
-
Thermo Fisher Scientific
-
Promega Corporation
*Disclaimer: Major Players sorted in no particular order
Oxidative Stress Assay Market News
- In June 2022, Dojindo, Japan launched the ROS Assay Kit for Photo-oxidation Resistant DCFH-DA. DCFH-DA is widely used for Reactive Oxygen Species detection.
- In February 2022, Invitae introduced FusionPlex Dx and LiquidPlex Dx in Europe. FusionPlex Dx is intended to be used as a CDx to aid in identifying patients diagnosed with NSCLC with ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) fusions, and others for whom treatment with targeted therapy may be beneficial.
Oxidative Stress Assay Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Defination
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rapid Growth in Biopharmaceutical and Biotechnology Industries
- 4.2.2 Increasing Investment in the Research and Development
-
4.3 Market Restraints
- 4.3.1 High Cost of the Equipment
- 4.3.2 Lack of Experienced Personnel
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Instruments
- 5.1.2 Consumables
- 5.1.3 Services
-
5.2 By Test Type
- 5.2.1 Indirect assays
- 5.2.2 Antioxidant capacity assays
- 5.2.3 Enzyme based assays
- 5.2.4 Reactive Oxygen species based assays
-
5.3 By Technology
- 5.3.1 Enzyme-linked Immunosorbent Assay (ELISA)
- 5.3.2 Flow Cytometry
- 5.3.3 Chromatography
- 5.3.4 Microscopy
- 5.3.5 Others
-
5.4 By Disease Type
- 5.4.1 Cardiovascular disease
- 5.4.2 Chronic Obstructive pulmonary disease (COPD)
- 5.4.3 Cancer
-
5.5 By End User
- 5.5.1 Pharmaceutical and Biotechnology Industries
- 5.5.2 Academic Research institutes
- 5.5.3 Clinical Research Organizations
-
5.6 Geography
- 5.6.1 North America
- 5.6.1.1 United States
- 5.6.1.2 Canada
- 5.6.1.3 Mexico
- 5.6.2 Europe
- 5.6.2.1 Germany
- 5.6.2.2 United Kingdom
- 5.6.2.3 France
- 5.6.2.4 Italy
- 5.6.2.5 Spain
- 5.6.2.6 Rest of Europe
- 5.6.3 Asia-Pacific
- 5.6.3.1 China
- 5.6.3.2 Japan
- 5.6.3.3 India
- 5.6.3.4 Australia
- 5.6.3.5 South Korea
- 5.6.3.6 Rest of Asia-Pacific
- 5.6.4 Middle East and Africa
- 5.6.4.1 GCC
- 5.6.4.2 South Africa
- 5.6.4.3 Rest of Middle East and Africa
- 5.6.5 South America
- 5.6.5.1 Brazil
- 5.6.5.2 Argentina
- 5.6.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abcam PLC
- 6.1.2 AMSBIO
- 6.1.3 Biovision Inc
- 6.1.4 Cell Biolabs, Inc
- 6.1.5 Enzo life sciences, Inc
- 6.1.6 Merck KGaA
- 6.1.7 ImmunoChemistry Technologies
- 6.1.8 Promega Corporation
- 6.1.9 Qiagen
- 6.1.10 Thermo fisher scientific
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityOxidative Stress Assay Industry Segmentation
As per the scope of this report, Oxidative Stress Assay is a type of assay which is used to identify and screen the level of oxidative stress markers and reagents in cells. The Oxidative Stress Assay Market is segmented by Product (Instrument, Consumables, And Services), Test Type (Indirect Assays, Antioxidant Capacity Assays, Enzyme Based Assays and Reactive Oxygen Species Based Assays), Technology Type (Enzyme-Linked Immunosorbent Assay(Elisa), Flow Cytometry, Chromatography, Microscopy and Others), Disease Type (Cardiovascular Disease, Chronic Obstructive Pulmonary Disease(COPD), Cancer), End User (Pharmaceutical And Biotechnology Industries, Academic Research Institutes And Clinical Research Organizations) and Geography (North America, Europe, Asia-Pacific, Middle East And Africa, And South America). The report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.
| By Product | Instruments | |
| Consumables | ||
| Services | ||
| By Test Type | Indirect assays | |
| Antioxidant capacity assays | ||
| Enzyme based assays | ||
| Reactive Oxygen species based assays | ||
| By Technology | Enzyme-linked Immunosorbent Assay (ELISA) | |
| Flow Cytometry | ||
| Chromatography | ||
| Microscopy | ||
| Others | ||
| By Disease Type | Cardiovascular disease | |
| Chronic Obstructive pulmonary disease (COPD) | ||
| Cancer | ||
| By End User | Pharmaceutical and Biotechnology Industries | |
| Academic Research institutes | ||
| Clinical Research Organizations | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Oxidative Stress Assay Market Research FAQs
What is the current Global Oxidative Stress Assay Market size?
The Global Oxidative Stress Assay Market is projected to register a CAGR of 9% during the forecast period (2024-2029)
Who are the key players in Global Oxidative Stress Assay Market?
Abcam plc, AMSBIO, Merck KGaA, Thermo Fisher Scientific and Promega Corporation are the major companies operating in the Global Oxidative Stress Assay Market.
Which is the fastest growing region in Global Oxidative Stress Assay Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Oxidative Stress Assay Market?
In 2024, the North America accounts for the largest market share in Global Oxidative Stress Assay Market.
What years does this Global Oxidative Stress Assay Market cover?
The report covers the Global Oxidative Stress Assay Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Oxidative Stress Assay Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Oxidative Stress Assay Industry Report
Statistics for the 2024 Global Oxidative Stress Assay market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Global Oxidative Stress Assay analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
